With the near readiness of the Corona vaccine … which Arab countries have guaranteed their share?


In an interview with Sky News Arabia, Al-Mandhari revealed that 11 countries will receive their needs by direct purchase, while 11 other countries will be eligible to receive assistance in order to obtain a share of the vaccine.

He explained that the countries that will get their vaccine needs by direct purchase are: the UAE, Saudi Arabia, Iran, Iraq, Lebanon, Jordan, Libya, Bahrain, Oman, Qatar and Kuwait.

The official spoke at World Health Organization 187 countries and economies have benefited from the facilities provided by “Kovacs”, including 92 low-income countries and economies eligible for assistance through advance market commitments.

When asked about the countries in the region closest to get The vaccine Al-Alamy within “Kovacs”, Al-Manzari said: “The matter depends first on the readiness and approval of vaccines.”

“Kovacs” is a mechanism designed to ensure rapid, fair and equitable access to pandemic vaccines.Covid-19“Around the world, when it becomes available.

Last September, the WHO announced that 64 countries had joined the mechanism.Kovacs“With the aim of ensuring that a vaccine against the Coronavirus reaches poor countries, when it is ready.

Fair distribution of safe vaccines

Al-Manzhar explained that the organization and its partners are working through the “Kovacs” mechanism to ensure “fair access to sufficient quantities of safe and effective vaccines against Corona for all countries, including those most in need and the least able to finance the purchase of the vaccine.”

According to the latest statistics in the countries of the Eastern Mediterranean Region, “Corona” infections approach 4 million cases, and deaths reach about 90,000, with an average mortality rate of 2.4%.

Al-Mandhari talked about the global organization’s moves to ensure fair access to safe vaccines all over the world, saying: “The distribution of vaccines after completion of their manufacture and availability for use will be on a fair basis that takes into account priority groups, and includes all countries regardless of their level of income and financial capabilities.”

For his part, said the general manager World Health OrganizationTedros Adhanom, in a statement issued recently, that the total commitment to support the Kovacs mechanism has reached 5.1 billion dollars, after the European Commission, France, Spain and South Korea pledged 360 million dollars.

He added, “With countries spending trillions of dollars to support economies, Kovacs represents the best possible way, as it will mean the fastest recovery for all.”

“Arrival date”

In order for the organization to ensure that all countries have access to the vaccine, Al-Mandhari stressed that it seeks to strengthen efforts to expand the manufacture of several vaccines, and to support the country’s production capabilities, in order to respond to the global demand for it.

The international official added, “At the same time, we are working with relevant partners to establish criteria for identifying priority groups to receive the vaccine, such as health sector employees, people with chronic diseases, pregnant women and the elderly.”

He also confirmed that by mid-2021, a safe and effective anti-corona virus vaccine manufactured and distributed worldwide will be available.

And he reported that the number of those vaccines reached more than 210; Of these, 48 vaccines have reached the stage of clinical trials, and 10 vaccines have reached the final stages of the third stage of human trials, and it is scientifically said that 10 percent of the candidate vaccines are successful and can be developed.

And he estimated that “we will have more than one vaccine based on the strong production line available to us now, which can lead to several safe and effective vaccines, and what is meant is the number of candidate vaccines that companies, agencies and countries have submitted to be subjected to experiments that prove their effectiveness and safety.”

Warning against the “vaccine nationwide”

While the World Health Organization recommends that high-income countries, which produce vaccines, not monopolize the quantities produced in the beginning, and be satisfied with 20 percent for each country, Al-Mandhari warned against the continuation of the epidemic in the event that poor countries are unable to obtain their necessary share of the vaccine.

And he added: “No one, or a country, will be safe from the pandemic unless everyone, the rich and the poor are safe from it. Therefore, we warn about the so-called nationwide distribution of vaccines, meaning that those who are able and producers acquire all the produced quantities of the vaccine without giving low-income countries the opportunity to obtain A share of it, or the able classes within the same country obtain the opportunity to buy the vaccine and deprive the poor who do not have the ability to buy it. “

Then he asserted firmly, “All this does not serve anyone … and we strive to prevent it from happening, and we believe that we are on the right path to achieve it.”

Efforts to tackle Pfizer’s challenges

Speaking about the challenges facing the American company “Pfizer” vaccine in terms of distribution, the official of the international organization said: “The Pfizer vaccine and other vaccines that companies announced the completion of trials on them give us a lot of hope for the approaching arrival of the vaccine.”

He added: “If the Pfizer vaccine, as its developers announced, requires a cold chain with a temperature of 80 degrees below zero, which is unfortunately not available in many countries, there are efforts being made to meet this challenge, and at the same time there are other vaccines whose preservation and transportation does not represent a major challenge to various countries. “.

The international official warned that World Health Organization It is awaiting official obtaining of all documents confirming the results of experiments conducted on these vaccines, which prove their effectiveness, safety, and passage of all recognized stages, “and only in this case can the organization approve this or that vaccine.”

A rising epidemic curve

When asked about the current epidemiological situation of Corona in the region, he explained that most countries in the region are witnessing an epidemic curve that is rising after a period of decline or stability, and this rise was caused by the easing of restrictions, the opening of institutions and public places, and the failure to observe preventive measures.

Al-Manzari recommends that governments take “complete seriousness” in applying procedures for monitoring and testing cases of infection, tracing contacts and treating cases in accordance with treatment protocols, and urging each individual or entity to play the required role, without surrendering to the state of fatigue with the pandemic, and laxity in implementing the required measures.


Please enter your comment!
Please enter your name here